. 2026 Oct 5;16(46):58950–58967. doi: 10.1039/d6ra07323a

Table 2. Substituent patterns and α-amylase inhibitory activity (IC₅₀) of additional oxadiazole–sulfonamide hybrids 11d–g derived from the scaffold previously discussed in the antimicrobial activity section.

Table 2. Substituent patterns and α-amylase inhibitory activity (IC50) of additional oxadiazole–sulfonamide hybrids 11d–g derived from the scaffold previously discussed in the antimicrobial activity section.